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ABSTRACT 
Background: Osteochondral defects (OCD) can affect the articular cartilage 
and subchondral bone tissues, which requires superior therapies for the 
simultaneous and full restoration of such structurally and biologically 
different tissues.  
Methods: Tissue engineered OC grafts were prepared using a horseradish 
peroxidase (HRP) approach to crosslink silk fibroin (HRP-SF) as the 
articular cartilage-like layer and an underlying HRP-SF/ZnSrTCP 
subchondral bone-like layer (HRP-SF/dTCP), through salt-leaching/freeze-
drying methodologies. In vivo OC regeneration was assessed by 
implantating the hierarchical scaffolds in rabbit critical size OC defects, 
during 8 weeks. A comparative analysis was performed using hierarchical 
OC grafts made of pure β-TCP (HRP-SF/TCP).  
Results: The hierarchical scaffolds showed good integration into the host 
tissue and no signs of acute inflammatory reaction, after 8 weeks of 
implantation. The histological analyses revealed positive collagen type II 
and glycosaminoglycans’ formation in the articular cartilage-like layer. 
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New bone ingrowth’s and blood vessels infiltration were detected in the 
subchondral bone-like layers.  
Conclusions: The proposed hierarchical scaffolds presented an adequate in 
vivo response with cartilage tissue regeneration and calcified tissue 
formation specially promoted by the ionic incorporation into the 
subchondral bone layer, confirming the hierarchical structures as suitable 
for OCD regeneration. 
KEYWORDS: silk fibroin; ZnSr-tricalcium phosphate; hierarchical 
scaffolds; horseradish peroxidase-mediated crosslinking; rabbit critical 
defect; osteochondral regeneration  
ABBREVIATIONS  
BMP-2, bone morphogenetic protein-2; CaPs, Calcium phosphates; ECM, 
extracellular matrix; GAGs, glycosaminoglicans; HAp, hydroxyapatite; 
HRP, horseradish peroxidase; OC, Osteochondral; OCD, Osteochondral 
defects; SF, silk fibroin; TE, Tissue Engineering; TCP, tricalcium phosphate 
INTRODUCTION  
Orthopedic surgeons have been facing major limitations in the 
development of personalized therapies to treat and regenerate 
osteochondral defects (OCD). These pathologies can simultaneously affect 
the articular cartilage and the subchondral bone, which implies advanced 
technological solutions to ensure the complete restoration of the two 
different tissues [1]. Cartilage defects are normally irreversible, 
considering its limited self-healing capacity and lack of vascularization. 
Subchondral bone has no such limitations, however, when an OCD reaches 
subchondral bone it means that articular cartilage has been deeply 
compromised. Another possible scenario is the loss of subchondral bone 
density that affects the support of articular cartilage from load bearing, 
resulting in cartilage tissue fracture and degeneration [2]. Diseases arising 
from articular cartilage can derived from natural degradation or trauma-
related injuries. The current methods used to treat OCD include non-
surgical therapies (drugs and/or physical therapy) and surgical 
techniques, depending on the severity of the defect. Arthroscopy, bone 
marrow stimulation (microfracture), the use of autografts or allografts, 
and cell-based therapy with autologous chondrocytes implantation, 
include the most common surgical methods used to treat OCD [3,4]. 
However, according to the orthopedic surgeons these are palliative and 
temporary solutions for improving the quality of life of patients, not 
ensuring the complete regenerative process of the OC tissue and the 
healing of mature hyaline articular cartilage [5]. With this in mind, OC 
tissue engineering (TE) strategies come to revolutionize the field of 
orthopedic surgery proposing promising alternatives for OCD repair and 
regeneration. Most of these strategies involve the individual or combined 
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application of scaffolds, cells and growth factors [6]. The initially proposed 
OC scaffolds were homogeneous structures used to simultaneously reach 
the needs of articular cartilage and subchondral bone [7]. Nowadays, the 
development of more complex and stratified heterogeneous structures 
was recognized as a better solution to treat OCD considering its 
hierarchical structure that contain specific mechanical properties and 
biological composition from the top articular cartilage layer to the 
underlying subchondral bone layer. Another important consideration for 
scaffolds design relies in the interface region between the articular 
cartilage and subchondral bone, also called as calcified cartilage [8]. This 
region has been considered by many authors as an additional layer for 
scaffolds production due to the recognition of its intermediate properties 
that do not fully fit into the articular cartilage nor in the subchondral bone 
properties [9]. Thus, bilayered, trilayered and multilayered scaffolds have 
been proposed for OCD repair and regeneration since they can better 
mimic the native structural complexity of OC tissue. These scaffolds should 
also include adequate macro-/micro-porosity, in some cases with different 
gradients and porous orientations [10]. For that, different processing 
technologies have been used, including solvent casting and particulate 
leaching, freeze-drying, phase separation and gas foaming, in combination 
with a wide range of natural and/or synthetic polymers [11]. The natural 
polymers are the most attractive for producing hydrogel-based scaffolds 
due to their aqueous nature, similarities to the native ECM and biological 
performance. The synthetic polymers usually present superior 
mechanical properties but slow biodegradability and less biocompatibility 
with human tissues [12]. Therefore, by means of combining synthetic- and 
natural-based biomaterials result in significantly enhanced mechanical 
and biological properties being proposed as marketed products for OC 
regeneration, but only a few have become clinically available. For 
example, the monolithic trilayered scaffold MaioRegen® composed by 
graded structures of collagen and magnesium enriched hydroxyapatite 
(HAp) and with a cartilage-bone interface that reproduced the tidemark of 
native OC tissue, have shown promising results for OC defects treatment 
[13]. However, one study has shown the non-homogeneous repair of OC 
tissue in the defective areas, which compromised the reliability of the 
product [14]. Another example is the cell-free biphasic scaffold TruFit®, 
made of a poly(lactic-co-glycolic acid)-poly(glycolic acid)/calcium-sulfate 
copolymer, which showed good short-term results of OCD repair in most 
of the patients [15,16], but in 2009 and in the following years, different 
reports exhibited foreign body reactions and lack of bone ingrowth, being 
then removed from the market in 2013 [17,18]. The Kensey Nash Cartilage 
Repair Device composed of collagen type I and β-tricalcium phosphate  
(β-TCP)[19], and the Agili-CTM composed of crystalline coral aragonite and 
hyaluronic acid [20], also include the class of cell-free bilayered scaffolds 
proposed to simultaneously regenerate hyaline cartilage and its 
underlying subchondral-bone layer.  
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Calcium phosphates (CaPs) are the main inorganic component of native 
bone tissue and the main constituent of tooth enamel, which makes them 
desirable for bone regeneration. Amongst CaPs, β-(Ca3(PO4)2) and HAp 
(Ca10(PO4)6(OH)2), have received particular attention owing their 
bioactivity and biocompatibility, and ability to be gradually absorbed in 
vivo and replaced by bone over time [21]. Nevertheless, these materials are 
brittle bringing out poor mechanical strength particularly for load-bearing 
applications, which can be solved by blending them with polymers, thus 
combining the stiffness of CaPs with the elastic properties of the polymeric 
matrices to form composites with improved mechanical properties for 
bone applications [1,22]. Incorporating trace elements existing in bone 
(e.g., Sr2+, Zn2+) into β-TCP structure has shown enhanced growth factors 
like bone morphogenetic protein-2 (BMP-2) and vascular endothelial 
growth factor production, as well improved mechanical properties and 
degradation control [23,24]. Those ionic elements play an essential part in 
the biological action course, for example Sr2+ encourages bone formation 
and has an inhibitory role on bone resorbing osteoclast cells [25], and Zn2+ 
is an essential trace element able to promote osteoblast cell proliferation 
and differentiation, and has anti-angiogenic effects by decreasing the 
expression of genes and growth factors enrolled in angiogenesis [26]. 
Silk fibroin (SF) protein has attracted much attention in TE field due to 
the extraordinary in vivo biocompatibility and biodegradability, as well as, 
excellent mechanical elasticity and flexibility [27]. It has been proposed as 
a biomaterial scaffold for orthopedic repair due to its fibrous structure 
similar to collagen type I and type II [28]. Moreover, the semi-amorphous 
and hydrophilic regions between the β-sheets of SF act as deposition sites 
of HAp nanoparticles mimicking the anionic structure of non-collagenous 
proteins [29]. Different studies have also reported that the SF crystalline 
phase can nucleate the deposition of HAp [30], and the presence of HAp 
blended with amorphous SF can induce conformational changes to the 
protein and presents superior mechanical performance [31]. Although SF 
protein has poor intrinsic capacities for bone regeneration, its blending 
with ceramic particles can not only be advantageous to improve the 
mechanical behavior of the biomaterials, but also to increase their 
osteogenic capacity in order to mimic the structure of native bone tissue.  
Highly porous 3D networks have been recognized as suitable for OC 
applications allowing cell infiltration and extracellular matrix (ECM) 
formation throughout the engineered cartilage and subchondral tissues. 
However, in some cases, the big challenge remains to obtain these 
architectures with adequate structural adaptability and resilient 
properties, necessary for a good integration into the host OC tissue. 
Hydrogel-based systems have been used for TE applications, containing a 
high water content that improves their elastic behavior and swelling 
capacity. Moreover, the hydrated nature of the hydrogels resemble the 
natural ECM of tissues, ensuring a suitable microenvironment for cell 
growth and protein delivery [32]. Recently, we have proposed a new 
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approach using horseradish peroxidase (HRP) to crosslink SF (HRP-SF) to 
form macro-/micro-porous scaffolds for cartilage and OCTE applications 
[11,33]. The developed hierarchical scaffolds, made of HRP-SF and HRP-SF 
containing β-TCP doped with zinc and strontium (HRP-SF/ZnSr-β-TCP), 
presented adequate structural integrity, superior mechanical properties, 
and excellent in vitro cell properties, particularly for the ion-doped 
structures [11]. Considering those results, herein was assessed a 
complementary in vivo evaluation of such hierarchical scaffolds, using a 
rabbit knee critical size OCD model. We hypothesize that the spatially 
limited incorporation of ZnSr-βTCP bioresorbable powder will affect the 
new bone ingrowth’s and mineralization, in comparison to the same 
structures with no ion incorporation.  
MATERIALS AND METHODS 
Materials and Reagents 
Bombyx mori cocoons were supplied by the Portuguese Association of 
Parents and Friends of Mentally Disabled Citizens (APPACDM, Castelo 
Branco, Portugal). All reagents were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) unless otherwise indicated.  
Preparation of Concentrated Aqueous SF Solution  
Bombyx mori cocoons were boiled in a sodium carbonate solution (0.02 
M) for 1 h to remove the glue-like protein sericin, and then rinsed 
thoroughly with distilled water (30 min) in order to completely extract the 
degumming solution. Purified silk fibroin (SF) was dissolved in a 9.3 M 
lithium bromide solution for 1 h at 70 °C, and dialyzed against distilled 
water using a benzoylated dialysis tubing (MWCO: 2 kDa) for 48 h. 
Afterwards, the aqueous SF solution was concentrated in a 20 wt.% 
poly(ethylene) glycol solution for at least 6 h. The final concentration of SF 
(∼20 wt.%) was determined by weighting the dry product of SF solution, 
left at 70 ºC overnight. The SF solution was stored at 4 °C until further use 
(Figure 1A).  
Preparation of HRP-Crosslinked SF/ZnSr-Doped β-Tricalcium 
Phosphate Hierarchical Scaffolds 
Highly concentrated SF solution was first diluted at 16 wt.% and a 
horseradish peroxidase (HRP)-crosslinked SF (HRP-SF) solution was 
prepared by mixing the SF (16 wt.%) with HRP solution (HRP type VI,  
0.84 mg/mL) and hydrogen peroxide solution (H2O2, 0.36 wt.%; Panreac, 
Barcelona, Spain). Briefly, 1 mL SF, 50 μL HRP and 65 μL H2O2 
(1/0.26‰/1.45‰) were mixed and used for preparing each layer of the 
hierarchical scaffolds. First, the subchondral bone-like layer was 
produced with 80/20 (w/w) ratio of HRP-SF/ZnSr-doped β-TCP and HRP-
SF/undoped β-TCP, used for comparison purposes. The β-TCP powders, 
pure and doped with 10 mol.% of Zn + Sr, were synthesized by aqueous 
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precipitation, followed by milling and sieving, with an average particle 
size of 1–10 µm, as previously described [34]. The ZnSr-β-TCP and β-TCP 
powders were mixed with the HRP-SF solution and transferred into 
cylindrical silicone molds (9 mm inner diameter; Deltalab, Barcelona, 
Spain), followed by adding 2 g of granular sodium chloride low in 
endotoxins (EMPROVE, VWR BDH Prolabo, Briare, France) sieved at  
500–1000 μm range (Analytic Sieve Shaker; AS 200 Digit, Retsch, Germany) 
(Figure 1A). After gelling at 37 °C in the oven, the molds were placed in 
distilled water and the salt extracted (porogen) during 72 h. Finally, the 
subchondral bone-like scaffolds were removed from the molds using a 
biopsy punch (8 mm inner diameter; Smith & Nephew, Forte da Casa, 
Portugal). The articular cartilage-like layer was produced on the top of the 
subchondral bone-like scaffolds, by placing the sample pieces into new 
silicon molds (8 mm inner diameter) covered by HRP-SF solution. Then,  
2 g of granular sodium chloride low in endotoxins (500–1000 μm) were 
added to the solution and left at 37 °C until complete gelation. After salt-
leaching process, the hierarchical scaffolds were punched (8 mm inner 
diameter), frozen at −80 °C and freeze-dried (Telstar Cryodos-80, Barcelona, 
Spain) for 7 days (Figure 1B). Monolayered HRP-SF, HRP-SF/ZnSr-β-TCP 
and HRP-SF/β-TCP scaffolds were prepared in parallel for bacteria growth 
evaluation. The scaffolds were abbreviated as HRP-SF/dTCP for 
monolayered HRP-SF/ZnSr-β-TCP scaffolds, HRP-SF/TCP for monolayered 
HRP-SF/β-TCP scaffolds, BdTCP for hierarchical HRP-SF|HRP-SF/dTCP 
scaffolds, and BTCP for hierarchical HRP-SF|HRP-SF/TCP scaffolds, 
according to the nomenclature previously described [11]. 
 
Figure 1. Schematic representation of the hierarchical scaffolds fabrication. (A) Aqueous silk fibroin (SF) 
extraction and purification for mixing with horseradish peroxidase (HRP) and hydrogen peroxide (H2O2) as 
crosslinking agents for preparing HRP-SF scaffolds. ZnSr-β-TCP and β-TCP particles incorporation in 80/20 
(w/w) ratio of HRP-SF/ZnSr-β-TCP and HRP-SF/β-TCP, respectively. (B) Methodology used for preparing the 
BdTCP and BTCP scaffolds, combining a salt-leached HRP-SF cartilage-like layer with HRP-SF/dTCP and HRP-
SF/TCP subchondral bone-like layers. 
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Figure 1. Cont. 
In vivo Implantation of the Hierarchical Scaffolds 
The in vivo OC regeneration potential of the hierarchical scaffolds was 
evaluated by their implantation in the knee of 12 male New Zealand white 
rabbits (Charles River Laboratories, Saint-Germain-sur-l’Arbresle, 
France). All the rabbits had 11 weeks and with an average weight of 2.9 kg, 
at the time of implantation. All animal procedures were based upon the 
“3Rs” policy (Replacement, Reduction and Refinement), and their 
maintenance and use were performed in accordance to the European 
Council Directives on Animal Care (Directive 2010/63/EU) and approved by 
the Ethics Committee of University of Minho and by the Portuguese 
Licensing Authority (DGV-DSSPA) in October, 2017.  
Hierarchical scaffolds of 5 mm in diameter and 5 mm in height (HRP-
SF layer: 2 mm height; HRP-SF/dTCP and HRP-SF/TCP layers: 3 mm height) 
were used for OCD implantation. The scaffolds were previously sterilized 
with ethylene oxide. In total, 6 rabbits (4 critical OC defects/rabbit) were 
used for implanting 12 hierarchical scaffolds (6 BdTCP; 6 BTCP). The 
rabbits were first anesthetized using a mixture of Ketamine (25 mg/mL) 
and metedomidine (0.15 mL/kg), and then the hair in the knee joints of the 
hind legs were shaved for disinfection of the limbs. 2 OCDs (5 mm in 
diameter and 5 mm in depth) were created in each femur using a Brace 
manual drill. First, an internal para-patellar rabbit incision was 
performed and the patella dislocated. The drills were made located 
between the lateral and the medial condyle, and in the opposite site of the 
patellar. A press fitting technique was used for the scaffolds implantation. 
In each rabbit, one of the defects was empty and used as control. The 
rabbits were euthanized 8 weeks post-operation and the knees excised. 
Explants were fixed in 10% formalin for 7 days at 4 °C, decalcified in  
TBD-2 (Thermo Scientific, Walthman, MA, USA) at room temperature (RT) 
for 7 days, and analyzed by different quantitative and qualitative 
techniques described below. 
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Micro-computed tomography analysis of the explants 
After fixation in formalin, the explants were analyzed by X-ray micro-
computed tomography (micro-CT) before and after decalcification. The 
scanning of the calcified and decalcified explants was conducted using a 
high-resolution X-ray micro-tomography system (Skyscan 1272; Bruker, 
Billerica, MA, USA), with a pixel size of 15 µm, a rotation step of 0.4° over 
360°, and a smoothing averaging of every 2–3 images. The acquisition 
parameters for bone mineral density quantification (g/cm3) in the calcified 
explants were based on a calibration phantom of 10 mm diameter, and 
equivalent density of 0.25 g/cm3 and 0.75 g/cm3. The X-ray source was fixed 
at 80 keV and 125 µA for the calcified explants, and the decalcified explants 
were scanned under 50 keV and 200 µA. The specimens were 
reconstructed from greyscale X-ray images using NRecon (version 1.7.1.0, 
Bruker, Billerica, MA, USA). The samples were vertically aligned for the 
analysis of proximal and distal regions using DataViewer software 
(version 1.5.3.6, Bruker, Billerica, MA, USA). Qualitative visualization of 
the 3D morphology and the different phases of the BdTCP and BTCP 
constructs were performed using CT-Vox software (version 3.3.0, Bruker, 
Billerica, MA, USA). In each specimen, a cylindrical model region of 
interest (5 mm in diameter and 5 mm in height) was used for the 
quantitative evaluation in the defects implanted with the hierarchical 
scaffolds, defect control and healthy control, performed using a CT 
Analyser (version 1.17.0.0, Bruker, Billerica, MA, USA). The top 1 mm 
region in the cylindrical model was attributed to the articular cartilage 
domain (0.5 mm to cartilage; 0.5 mm to calcified cartilage), and the 4 mm 
in the region down were considered as subchondral bone domain, 
according to the thickness of normal articular cartilage and subchondral 
bone in rabbit knees. Soft and hard tissue content was assessed applying a 
threshold respectively of, 25–60 and 60–255. 
Histology and immunofluorescence staining of the explants 
The decalcified explants were dehydrated through increasing ethanol 
concentrations, and finally embedded in paraffin. All specimens were 
sectioned with 5 µm thick using a microtome (Spencer 820, American 
Optical Company, NY, USA). The obtained sections were stained with 
haematoxylin and eosin (H&E; Thermo Scientific, Waltham, MA, USA) to 
evaluate tissue distribution within the constructs layers, Masson’s 
trichrome (Bio-Optica staining kit, Milan, Italy) to detect collagen content, 
and Safranin-O (0.1% v/v; Honeywell Fluka, Morris Plains, NJ, USA) to 
detect glycosaminoglycan’s (GAGs) formation and distribution in the 
articular cartilage layer. For Safranin-O staining, sections were 
counterstained with Gill-2 haematoxylin (Thermo Scientific, Walthman, 
MA, USA) and Fast green (0.02% v/v; Honeywell Fluka, Morris Plains, NJ, 
USA). 
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To detect collagen type II protein expression, a monoclonal mouse anti-
rabbit collagen type II alpha 1 chain-purified (Col II; Acris Antibodies 
GmbH, Herford, Germany) primary antibody was used following the 
protocol provided by the supplier. Briefly, after deparaffination and 
rehydration of the slides, antigen retrieval was performed by incubating 
slides in 0.5% pepsin in 5 mM HCl (Fisher Scientific, Waltham, MA, USA) 
for 45 min at 37 °C, and then the endogenous peroxidases were inactivated 
by using 3% (v/v) H2O2 solution. For Col II immunofluorescence staining, 
the specimens slides were incubated overnight at 4 °C with the primary 
antibody (dilution 1:50). Then, the slides were incubated with the 
respective secondary fluorochrome-conjugated antibody Alexa Fluor 594 
donkey anti-mouse IgG (Invitrogen, Life Technologies, California, USA; 
dilution 1:100). The nuclei of the cells were counterstained with  
4,6-diamidino-2-phynylindole (DAPI; Biotium, CA, USA; dilution 1:500) 
solution for 30 min. Slides incubated only with the secondary 
fluorochrome-conjugated antibody were used as negative control.  
A transmitted and reflected light microscope (Axio Imager Z1 m; Zeiss, 
Jena, Germany) was used for histological and immunofluorescent (Col type 
II in red, ex/em 594/618; DAPI in blue, ex/em 358/461) analysis. Images 
were obtained using the Zen microscope software (Zeiss, Jena, Germany), 
connected to the digital cameras AxioCam MRc5 and MR3 (Zeiss, Jena, 
Germany). 
Statistical Analysis 
All the numerical results are presented as mean ± standard deviation 
(SD). Statistical analysis was performed using the GraphPad Prism 5.0 
software (GraphPad Software, La Jolla, CA, USA), where a Shapiro-Wilk 
normality test was first performed to ascertain the data normality. The 
results indicated that a non-parametric test should be applied for 
quantitative micro-CT results, being therefore analyzed by means of a 
Mann-Whitney test, and carried out with at least 3 replicates for each 
condition.  
RESULTS 
Regeneration of Rabbit Knee OCD by the Hierarchical Scaffolds 
Integration and OC tissue formation on the hierarchical scaffolds 
The potential of the BdTCP and BTCP scaffolds to regenerate OCD was 
assessed by implanting the structures up to 8 weeks into OCD induced in 
rabbit knees. From the macroscopic images (Figure 2A), it can be observed 
that the scaffolds were well integrated into the host tissue with no signs of 
infection. The defect control showed regenerated tissue and no signs of 
adjacent collapsed tissue. The 2D cross-sections and 3D reconstructions of 
the explants obtained from micro-CT analysis, confirmed that the 
hierarchical scaffolds presented a regular morphology filling the defect 
area. It was observed cartilage tissue formation in the surface area of the 
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implants, and trabecular subchondral bone tissue presented in the bottom 
domain of the scaffolds, as compared to the defect control. Although from 
the 3D reconstructions it is not distinguishable if the calcified component 
(red) belongs to the TCP in the scaffolds or to the calcified tissue in the new 
bone, based on the scanning parameters (high voltage) chosen for these 
assays and on the calcified component also identified in the native 
subchondral bone tissue of the rabbit models (white arrows), we believe 
that a high amount of the detected CaP may came from the newly formed 
subchondral bone. The quantitative micro-CT data showed that the BdTCP 
scaffolds presented no significant differences of the mean porosity (Figure 
2B) and mean trabecular thickness (Figure 2C), in comparison to the 
healthy control. On the contrary, the defect control and BTCP scaffolds 
presented a mean porosity (* P-value = 0.0121 and + P-value = 0.0357) and 
mean trabecular thickness (^ P-value = 0.0121) significantly lower than 
that of the healthy control. The pore size distribution showed that the 
BdTCP scaffolds were empty in the bottom region of the subchondral 
trabecular bone, similarly to the healthy control, and were gradually filled 
by the tissue until the top articular cartilage region. The defect control and 
BTCP scaffolds showed <2 mm mean pore size in the analyzed region. The 
defects implanted with the hierarchical scaffolds presented a higher bone 
mineral density (BMD) in the subchondral bone region, corresponding to 
the HRP-SF/dTCP and HRP-SF/TCP layers, which decreased in the articular 
cartilage region of the HRP-SF layers. The healthy control showed a large 
BMD in the subchondral bone plate and calcified cartilage, corresponding 
to the areas of higher bone mineral density and lower porosity in the 
native OC tissue of the rabbit models. 
The profile of tissue distribution along the defects implanted with 
BdTCP scaffolds (Figure 3A), BTCP scaffolds (Figure 3B), healthy control 
(Figure 3C), and defect control (Figure 3D), showed an increase of the 
tissue filled from the trabecular bone region to the calcified cartilage 
region. The subchondral bone region of the defects implanted with BdTCP 
scaffolds was filled by hard and soft tissue at similar levels, while the 
articular cartilage region showed higher soft tissue distribution. Such 
behavior was not observed on the remaining conditions, presenting 
higher soft tissue content distributed along the analyzed region. Compared 
to the healthy control, the implanted defects and the defect control showed 
higher tissue regeneration in the subchondral bone region.  
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Figure 2. Structural characterization of the explants after implantation in rabbit knee OCD for the period of 
8 weeks. (A) Macroscopic images, micro-CT 3D reconstructions and 2D cross-sections (transversal view in 3 
different axis), and H&E staining of the explants. The black arrows indicate the implanted BdTCP and BTCP 
scaffolds, the red arrows indicate the defect control, and the white arrows indicate native subchondral bone 
tissue in the rabbit models. (B) Mean porosity, (C) mean trabecular thickness, and profiles of (D) pore size 
distribution, and (E) bone mineral density distribution along the pre-defined subchondral bone region and 
articular cartilage region of interest in the defects implanted with BdTCP scaffolds, defects implanted with 
BTCP scaffolds, healthy control, and defect control. Mean porosity and mean trabecular thickness data 
expressed as mean ± standard deviation (SD). *,+,^ Statistically significant when compared with healthy 
control (* P-value = 0.0121; + P-value = 0.0357; ^ P-value = 0.0121). Healthy control (n = 3); Defect control  
(n = 8); BdTCP and BTCP (n = 5). 
Regen Med Front. 2019;1:e190007. https://doi.org/10.20900/rmf20190007 
 
Regenerative Medicine Frontiers 12 of 22 
 
Figure 3. Profiles of soft, hard and whole tissue distribution along the pre-defined subchondral bone region 
and articular cartilage region of interest in the (A) defects implanted with BdTCP scaffolds, (B) defects 
implanted with BTCP scaffolds, (C) healthy control, and (D) defect control.  
Histological characterization and immunodetection of neocartilage-
forming protein  
The explants were further evaluated by Masson’s trichrome and 
Safranin-O staining to identify the collagen deposition and the new bone 
tissue, as well as, GAGs formation at the newly formed ECM, respectively 
(Figure 4). It was possible to confirm that the implanted hierarchical 
scaffolds were well integrated and presented structural stability within 
the newly formed tissues. From Masson’s trichrome staining images 
(Figure 4A,B), it was found collagen deposition and a thick new cartilage 
layer surrounding the porous structures of the top HRP-SF layers, 
especially on the BdTCP scaffolds. The chondrocytes in the neocartilage 
tissue presented a typical round morphology. In the bottom domain, new 
subchondral bone growth and blood vessels infiltration were observed 
within the HRP-SF/dTCP (Figure 4D) and HRP-SF/TCP (Figure 4E) porous 
structures, which shows a good integration of the scaffolds in the host 
tissue. Moreover, the infiltration of the new bone was limited to the 
subchondral bone-like layers. The defect control also showed cartilage 
regeneration (Figure 4C) and new bone formation (Figure 4F), however the 
presence of void spaces in this region reflected some instability of the 
newly formed tissue (Figure 4F,L). From Safranin-O staining, it can be 
confirmed the formation of neocartilage tissue on the top region of the 
BdTCP and BTCP scaffolds, by the presence of a GAGs matrix extended into 
the porous HRP-SF layers (Figure 4G,H). As expected, the bottom HRP-
SF/dTCP (Figure 4J) and HRP-SF/TCP (Figure 4K) layers showed no positive 
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staining for GAGs, indicating that the formation of new cartilage was 
exclusively to the top cartilage-like layers. The defect control also 
presented positive staining for GAGs (Figure 4I), however the formed 
cartilage matrix was randomly distributed. From H&E staining (Figure 
4M,N), large blood vessels infiltration are easily identified as indicated by 
the yellow arrows. 
 
Figure 4. Histological analysis of the explants after implantation in rabbit knee OCD for 8 weeks. (A–F) 
Masson’s trichrome and (G–L) Safranin-O staining of the longitudinal sections of the explants. Masson’s 
trichrome staining of the explants in the (A–C) cartilage region and in the (D–F) subchondral bone region of 
the (A,B,D,E) implanted and (C,F) defect control. Safranin-O staining of the explants in the (G–I) cartilage 
region and in the (J–L) subchondral bone region of the (G,H,J,K) implanted and (I,L) defect control. (M,N) 
H&E staining of the explants in the subchondral bone region of the BdTCP and BTCP scaffolds. The black 
arrows indicate collagen (blue) and GAG’s (red) deposition in neocartilage tissue formation and infiltration 
within the HRP-SF layers of the BdTCP and BTCP scaffolds. The pink arrows indicate chondrocytes. The red 
arrows indicate new bone tissue (red) formation surrounded by immature fibrous connective tissue (blue; 
green arrows). The yellow arrows indicate blood vessels (orange). “S” indicates stained scaffolds (HRP-SF, 
HRP-SF/dTCP, and HRP-SF/TCP). 
From Col II immunofluorescence analysis, the formation of 
neocartilage tissue inside the porous HRP-SF layers of the BdTCP  
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(Figure 5A) and BTCP (Figure 5B) scaffolds was confirmed. The defect 
control also showed positive staining of Col II (Figure 5C). 
 
Figure 5. Col II immunofluorescence analysis of the explants. (A–C) Col II staining for the neocartilage 
formed in the HRP-SF layer of the BdTCP and BTCP scaffolds, and in the surface area of the defect control, 
respectively. (D–F) Negative control for A-C, respectively. In representative immunofluorescence images, 
the nuclei are stained in blue and Col II is stained in red. “S” indicates HRP-SF scaffolds autofluorescence in 
blue, and the white arrows indicate Col II in the regenerated cartilage. 
DISCUSSION 
OC tissue regeneration remains a big challenge for TE researchers and 
orthopedic surgeons. The high complexity of OC tissue relies in its dual 
structural, biochemical and cellular composition. In the avascular 
chondral layer reside chondrocytes, surrounded by a highly aqueous ECM 
composed by collagen type II and proteoglycans. On the other side, a 
highly vascularized subchondral bone layer is composed by different 
types of cells (e.g., bone marrow cells, osteoblasts, osteocytes and 
osteoclasts), collagen type I and the inorganic phase HAp [7]. Thus, when 
considering a scaffold as an innovative strategy to OCD treatment, 
different features should be considered. It has been recognized that 
bilayered scaffolds composed by specific mechanical, chemical and 
morphological properties in each layer, are more likely to simultaneously 
satisfy the regeneration of the articular cartilage and subchondral bone 
tissues [1]. Moreover, advances have been made for the fabrication of an 
intermediate region that mimics the interface between the two layers and 
interconnects their distinct properties [35]. For example, Ding et al. [36] 
developed integrated OC composite scaffolds containing three layers. The 
top cartilage layer was made of SF presenting longitudinal orientation and 
microtubular structure, whereas the lower subchondral bone layer 
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presented a highly porous three-dimensional (3D) structure composed of 
SF and HAp. A dense intermediate region also composed of SF/HAp served 
as boundary between the chondral and subchondral bone layers. The 
scaffolds showed bioactivity and supported human adipose-derived stem 
cells differentiation towards chondrocytes and osteoblasts in vitro. The 
existence of a dense intermediate region also prevented the mixing of the 
cells between the chondral and the bone layers, favoring the 
differentiation pattern on the respective layers of the scaffolds.  
Fully integrated SF/SF-nanoCaP hierarchical scaffolds were also 
proposed by Yan et al. [37] for OCD regeneration. The authors used salt-
leaching/freeze-drying methodologies to form highly porous structures 
with homogeneous pore distribution along the scaffolds. The integration 
of a SF-based cartilage like layer with a SF/nano-CaP subchondral bone-
like layer allowed to obtain hierarchical structures with distinct but 
interconnected properties. The CaP phase was only retained on the 
underlying subchondral bone layer (SF-nanoCaP) improving the 
mechanical properties of scaffolds and the osteogenic activity of rabbit 
bone marrow mesenchymal stromal cells. Moreover, in rabbit knee OCD, 
the firmly integrated scaffolds showed collagen type II positive staining 
and GAGs formation on the top SF layer, together with new bone ingrowth 
and blood vessels infiltration on the underlying SF-nanoCaP layer [38–40]. 
The suitability of macro-/micro-porous HRP-crosslinked SF scaffolds for 
cartilage TE applications was also demonstrated in our previous works 
[33]. These structures presented combined features of chemically and 
mechanically stable SF scaffolds, with the elastic behavior of 
enzymatically crosslinked SF hydrogels [41,42].  
As aforementioned, hydrogel-based networks are attractive for 
building 3D structures for OC tissue regeneration, that resemble the ECM 
due to their high water content, viscoelastic nature, and the easy diffusion 
of biomacromolecules. Thus, the possibility of structuring hydrogel-based 
matrices in order to increase their porosity for guiding cell infiltration, 
orientation and ECM formation is of paramount importance for OC tissue 
regeneration. For example, Canadas et al. [43] developed a novel 3D OC 
tissue model made of methacrylated gellan gum blended with gelatin and 
produced both with linear and random porosity distribution, using 
temperature gradients and freeze-drying process. The porous hydrogels 
presented isotropic and anisotropic structures with different pore sizes 
and porosity according to the OC layer. It was also showed different 
gradient distributions using HAp micro-particles in combination with 
growth factors, which contributed for the formation of a heterotypic-like 
OC tissue with different cell orientations according to the chondral or 
subchondral layer. We have recently developed HRP-SF to form macro-
/micro-porous scaffolds using salt-leaching/freeze-drying methodologies 
for cartilage TE applications [33]. The obtained structures have shown the 
ability to support human adipose derived stem cells, chondrogenic 
differentiation and cartilage-like ECM formation within the 
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interconnected porous matrices. Additionally, with the applied 
methodologies the crystallinity of SF protein increased thus improving the 
scaffolds mechanical properties and structural stability, as compared to 
pure HRP-crosslinked SF hydrogels produced with amorphous 
conformation [41]. On the basis of these findings, we have further 
developed novel hierarchical scaffolds integrating the HRP-crosslinked SF 
scaffolds as articular cartilage-like layer, into an underlying HRP-
crosslinked SF scaffolds containing β-TCP doped with zinc and strontium 
(HRP-SF/ZnSr-β-TCP), as subchondral bone-like layer [11]. The scaffolds 
presented adequate structural integrity, homogeneous porosity 
distribution and the TCP phase confined to the subchondral bone-like 
layer. As major particularities, these structures presented resilient 
properties and viscoelastic nature for an easy adjustment to fill OCD. The 
in vitro biomineralization capability of the bilayered scaffolds after 
soaking in a simulated body fluid for 15 days, showed the formation of a 
cauliflower-like apatite layer, mainly due to the presence of Sr and Zn 
trace elements. Furthermore, in vitro response of co-cultured human 
osteoblasts and human chondrocytes showed an outstanding performance 
for cell adhesion, proliferation, and ECM production, owing the chemical 
properties of SF, the crystalline structure of β-TCP and the presence of 
ionic dopants. It was also observed osteogenic activity and chondrogenic 
inducement, respectively represented by the formation of a mineralized 
matrix and GAGs deposition, in the subchondral and chondral-like layers. 
In the interface region, the genotypic expression of Col X, as a marker of 
pre-hypertrophic chondrocytes, confirmed the hierarchical and stratified 
properties of the ion incorporation into the hierarchical scaffolds. 
Although worthy outcomes have been obtained so far, a complementary 
in vivo evaluation was demanded to observe the overall effects of those 
biofunctional structures in a living OCD. Therefore, in the present study, 
rabbit knee OCD were used as animal model to induce the OC regeneration 
potential of the hierarchical scaffolds. It was observed that the fixation of 
the implanted scaffolds was easy, while maintaining their dimensions 
over the implantation period (Figure 2A). It has been reported that the 
swell behavior of the scaffolds can be a problem for the implantation and 
in some cases, their fixation can be also compromised [44]. Herein, an 
expected swelling was reached in order to completely fill the empty space 
of the defects, however, no protrusions or signs of acute inflammatory 
reaction were observed. The results may be related to the resilient and 
viscoelastic properties of the HRP-crosslinked hierarchical scaffolds [11], 
which contributed to the superior structural stability. From the 3D 
reconstructions of the explants, the regular morphology and good stability 
of the scaffolds filling the defect area were confirmed, as well as, the 
proposed structures were able to support the cartilage tissue formation 
and the subchondral bone regeneration, with a high content of CaP 
detected in the HRP-SF/dTCP and HRP-SF/TCP layers. Confirming these 
observations, the BMD distribution within the subchondral bone layers of 
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the BdTCP and BTCP scaffolds was superior to that observed in the top of 
HRP-SF layers (Figure 2E). Previously, Yan et al. [37] showed that the good 
integration of SF/SF-nanoCaP porous hierarchical scaffolds in rabbit knee 
OCD enable a rapid subchondral bone regeneration after 4 weeks of 
implantation. The fast formation of new subchondral bone tissue is critical 
to fix the implants into the defect sites, but also to provide mechanical 
support for the subsequent regeneration of articular cartilage tissue [45]. 
The authors also observed a small amount of subchondral bone tissue in 
the empty defects, contrary to the high content of regenerated tissue 
observed in the defect controls of our study, after a longer implantation 
period (8 weeks). The good outcomes of the ionic presence into the 
hierarchical scaffolds were confirmed by the similar porosity (Figure 2B), 
trabecular thickness (Figure 2C), and pore size distribution (Figure 2D) of 
the BdTCP scaffolds to that obtained for the healthy controls. Moreover, in 
the subchondral bone region the BdTCP scaffolds were filled by hard and 
soft tissue at similar levels (Figure 3A), which indicates the strong impact 
of Zn and Sr elements on bone formation and mineralization, by means of 
improving the microstructure and crystallinity of β-TCP [34,46]. 
The OC tissue regeneration was further analyzed by histology and 
immunohistochemistry. The main indicators of articular cartilage tissue 
formation in OCD regeneration, are the formation of the specific hyaline 
cartilage components GAG’s and Col II [47]. In the present study, we were 
able to observe the collagen deposition and GAGs matrix formation on the 
top HRP-SF layers of the BdTCP (Figure 4A,G) and BTCP (Figure 4B,H) 
scaffolds, indicating that these structures were advantageous in 
supporting neocartilage tissue formation. These observations were also 
confirmed by the cartilage-specific protein expression of Col II in this 
region (Figure 5A,B). The infiltration of chondrocytes and newly formed 
cartilage within the porous structure of the top HRP-SF layers, revealed the 
importance of a high and controlled porosity in cell infiltration, 
proliferation and ECM formation [47,48]. When observing tissue 
formation within the HRP-SF/dTCP (Figure 4D) and HRP-SF/TCP (Figure 4E) 
layers, new bone ingrowth and blood vessel infiltration were clearly 
observed (Figure 4M,N). The availability of good vascularization pathways 
is another important issue when considering a scaffold for OCD 
regeneration and rapid subchondral bone formation [49]. Once again, the 
production of highly porous structures may have contributed to the 
obtained results [50]. Thus, the in vivo results revealed that the 
hierarchical scaffolds support rabbit knee OCD regeneration. 
CONCLUSIONS 
In this study, the in vivo performance of hierarchical scaffolds made of 
HRP-SF and HRP-SF/ZnSrTCP layers respectively, as the articular cartilage-
like layer and an underlying subchondral bone-like layer, was assessed 
using rabbit critical size OC defects. The hierarchical scaffolds presented 
good integration into the host tissue and no signs of acute inflammatory 
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reaction, after 8 weeks of implantation. Histological and 
immunofluorescence analyses confirmed the cartilage tissue regeneration, 
as observed by the presence of GAGs and collagen type II positive 
staining’s in the HRP-SF layer. De novo bone ingrowth and blood vessels 
infiltration were also observed on the underlying HRP-SF/ZnSr-β-TCP and 
HRP-SF/β-TCP layers, suggesting that the presence of inorganic ionic-
doped β-TCP promoted subchondral tissue formation. Although long-term 
studies are needed to ensure the beneficial effect of the ionic presence, as 
well the implant-tissue interactions and resorption, the results herein 
obtained suggest that the proposed hierarchical scaffolds may be 
potentially used in OCD regeneration. 
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